Standard Family Office’s NovoCure NVCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-27	Closed	-$2K	–	307
2022 Q3	$2K	Hold	27	–	–	﹤0.01%	408
2022 Q2	$2K	Buy	+27	New	+$2K	0.02%	171
2021 Q3	–	Sell	-9	Closed	-$2K	–	378
2021 Q2	$2K	Buy	+9	New	+$2K	﹤0.01%	409